Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Cheney

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|March 26, 2016
Atropisomer Control in Macrocyclic Factor VIIa InhibitorsPeter W Glunz, Luciano Mueller, Daniel L Cheney, et al.
Journal of Molecular Graphics & Modelling|June 12, 2003
Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for successAndrew C Good, Daniel L Cheney, Doree F Sitkoff, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2007
Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modificationsJennifer X Qiao, Tammy C Wang, Gren Z Wang, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2007
Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide coreJon J Hangeland, Daniel L Cheney, Todd J Friends, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa InhibitorsJeremy M Richter, Daniel L Cheney, J Alex Bates, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: discovery of novel, highly potent inhibitors of Factor XaJennifer X Qiao, Daniel L Cheney, Richard S Alexander, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2016
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitorsVladimir Uladzimir Ladziata, Peter W Glunz, Yan Zou, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Optimization of the beta-aminoester class of factor Xa inhibitors. Part 1: P(4) and side-chain modifications for improved in vitro potencyMark Czekaj, Scott I Klein, Kevin R Guertin, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moietyEdwin J Iwanowicz, Scott H Watterson, Junqing Guo, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor XaJennifer X Qiao, Chong-Hwan Chang, Daniel L Cheney, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|March 26, 2016
Atropisomer Control in Macrocyclic Factor VIIa InhibitorsPeter W Glunz, Luciano Mueller, Daniel L Cheney, et al.
Journal of Molecular Graphics & Modelling|June 12, 2003
Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for successAndrew C Good, Daniel L Cheney, Doree F Sitkoff, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2007
Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modificationsJennifer X Qiao, Tammy C Wang, Gren Z Wang, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2007
Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide coreJon J Hangeland, Daniel L Cheney, Todd J Friends, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa InhibitorsJeremy M Richter, Daniel L Cheney, J Alex Bates, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: discovery of novel, highly potent inhibitors of Factor XaJennifer X Qiao, Daniel L Cheney, Richard S Alexander, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2016
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitorsVladimir Uladzimir Ladziata, Peter W Glunz, Yan Zou, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Optimization of the beta-aminoester class of factor Xa inhibitors. Part 1: P(4) and side-chain modifications for improved in vitro potencyMark Czekaj, Scott I Klein, Kevin R Guertin, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moietyEdwin J Iwanowicz, Scott H Watterson, Junqing Guo, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor XaJennifer X Qiao, Chong-Hwan Chang, Daniel L Cheney, et al.
Pageof 5